Dr Sulaiman Al Habib Medical Services Group Company SJSC
Dr Sulaiman Al Habib Medical Services Group Company SJSC operates as a provider of healthcare services and facilities in the healthcare sector.
Business. Dr Sulaiman Al Habib Medical Services Group Company SJSC operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Saudi Arabia and is primarily listed on the Tadawul exchange under the ticker symbol 4013.SE. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Analyst recommendations
15 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Dr Sulaiman Al Habib Medical Services Group Company SJSC operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Saudi Arabia and is primarily listed on the Tadawul exchange under the ticker symbol 4013.SE. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Dr Sulaiman Al Habib Medical Services Group Company SJSC has a basic and diluted share count of 350,000,000 shares outstanding, indicating no dilution from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and return metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided for comparison. This limits the ability to assess the company's performance relative to its peers in the Healthcare Facilities & Services industry.
The company's geographic and segmental exposure is not disclosed in the available data, making it difficult to evaluate revenue concentration or diversification across business lines or regions.
Growth trajectory is not quantified in the outlook, and no numeric deltas are provided for the current or next fiscal year. Analysts have issued a mean price target of 294.14 SAR, with a median of 296.50 SAR, suggesting a generally positive sentiment.
Risk factors include the inability to assess liquidity risk, and while dilution is currently rated as low, the absence of balance-sheet data limits the ability to evaluate credit risk or capital structure stability.
Recent events or filings are not detailed in the available data, and no transcripts or disclosures are provided to inform recent strategic or operational developments.
- The company has no dilution from stock options or convertible instruments, with basic and diluted shares outstanding equal at 350,000,000.
- Analysts have issued a mean price target of 294.14 SAR, with a median of 296.50 SAR, indicating a generally positive outlook.
- Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
- No industry-specific preferred metrics are available for comparison, limiting the ability to assess performance relative to peers.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 7,55 |
| Revenue | —no estimate | —no estimate | 15,6B SAR |
| Operating income | —no estimate | —no estimate | 3,0B SAR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Dr Sulaiman Al Habib Medical Services Group Company SJSC Market data — financials · 2026-05-26
- Dr Sulaiman Al Habib Medical Services Group Company SJSC Market data — analyst estimates · 2026-05-26
- Dr Sulaiman Al Habib Medical Services Group Company SJSC Market data — ESG · 2026-05-26